WCN24-889 BASILIXIMAB INDUCTION, STEROID USE AND RECURRENCE OF IGA NEPHROPATHY IN RENAL TRANSPLANT PATIENTS

WCN24-889 BASILIXIMAB INDUCTION, STEROID USE AND RECURRENCE OF IGA NEPHROPATHY IN RENAL TRANSPLANT PATIENTS

Saved in:

Bibliographic Details
Main Authors:	Isabela Bertoni, Matthew Brook, Paul Harden, Ian Roberts, Maria Soares
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924010404
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1131 OUTCOMES OF LIVE RELATED RENAL TRANSPLANT RECIPIENTS WITH THE USAGE OF ATLG VS BASILIXIMAB AS AN INDUCTION AGENT
by: Ruchir Dave, et al.
Published: (2024-04-01)

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
by: Mateus Luvizotto, et al.
Published: (2024-04-01)

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN24-2478 PODOCYTOPATHY ASSOCIATED WITH IGA NEPHROPATHY: IS IT REALLY A PROGNOSTIC FACTOR?
by: BELENGALLEGOS VAZQUEZ, et al.
Published: (2024-04-01)

Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy
by: Jing Miao, et al.
Published: (2024-01-01)

WCN24-1347 CLINICAL PRESENTATION AT THE TIME OF DIAGNOSIS IN A COHORT OF MEXICAN PATIENTS WITH IGA NEPHROPATHY
by: Estefania Garduño Hernandez, et al.
Published: (2024-04-01)

WCN24-2270 COMPLEMENT SYSTEM IS OVERACTIVATED IN PATIENTS WITH IGA NEPHROPATHY AFTER COVID-19 INFECTION
by: Hong Cheng, et al.
Published: (2024-04-01)

WCN24-1383 ADHERENCE TO INTERNATIONAL GUIDELINES FOR THE TREATMENT OF A COHORT OF MEXICAN PATIENTS WITH IGA NEPHROPATHY
by: Estefania Garduño Hernandez, et al.
Published: (2024-04-01)

WCN24-2062 CLINICOPATHOLOGICAL CHARACTERISTICS AND LONG-TERM PROGNOSIS OF IgA NEPHROPATHY PATIENTS WITH NEPHROTIC SYNDROME
by: xiaoling zhou, et al.
Published: (2024-04-01)

WCN24-733 Treatment decision-making modle for IgA nephropathy: a real-world study
by: Ying Zheng, et al.
Published: (2024-04-01)

WCN24-1121 Novel IgA type autoantibodies against mesangial autoantigen, βIIspectrin, are specifically detected in patients with IgA nephropathy
by: Kazuaki Mori, et al.
Published: (2024-04-01)

WCN24-743 BLIND SPOT IN THE RADAR OF MEST-C SCORE: TYPE AND SEVERITY OF TUBULOINTERSTITIAL NEPHRITIS IN IGA NEPHROPATHY
by: Aurangzeb Afzal, et al.
Published: (2024-04-01)

WCN24-1197 EFFICACY AND SAFETY OF RAVULIZUMAB IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL IN IgA NEPHROPATHY
by: Jonathan Barratt, et al.
Published: (2024-04-01)

WCN24-2601 RARITY OF IGA NEPHROPATHY IN AFRICA: EVIDENCE FROM A 10YEAR REVIEW OF RENAL BIOPSIES IN EAST AFRICA - A POINTER TO THE GEOGRAPHICAL AND RACIAL DISPARITY OF IGA NEPHROPATHY IN AFRICA
by: Ahmed Kalebi
Published: (2024-04-01)

WCN24-2599 EFFICACY AND SAFETY OF BUDESONIDE IN IGA NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: João Lucas de Magalhães Leal Moreira, et al.
Published: (2024-04-01)

WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY
by: Hernán Trimarchi, et al.
Published: (2024-04-01)

Acute Transient Hyperglycemia After Steroid Induction at Transplant Strongly Predicts New-Onset Diabetes and Recurrence of Diabetic Nephropathy
by: Carlotta Federica Zizzi, et al.
Published: (2024-03-01)

WCN25-1435 VISUALIZATION OF THE MESANGIAL-CELL-SURFACE AUTOANTIGENS IN IGA NEPHROPATHY
by: Kazuaki Mori, et al.
Published: (2025-02-01)

WCN25-4525 IGA NEPHROPATHY CLINICOPATHOLOGICAL ASSOCIATION WITH MEST-C SCORING
by: Meghana Rao C, et al.
Published: (2025-02-01)

WCN24-1104 Finding of CD4+ T cells infiltrating the kidney of gddY mouse, IgA nephropathy animal model
by: Hiroyuki Iwasaki, et al.
Published: (2024-04-01)

WCN24-1565 EFFECT OF PHOSPHODIESTERASE V INHIBITOR ON FIBROBLAST DERIVED FROM BIOPSY SPECIMEN OF IgA NEPHROPATHY: AN IN-VITRO STUDY
by: Manas Ranjan Behera, et al.
Published: (2024-04-01)

WCN24-773 SPARSENTAN AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY: PRELIMINARY FINDINGS FROM THE SPARTAN TRIAL
by: Chee Kay Cheung, et al.
Published: (2024-04-01)

Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.
by: Yu-Hao Zhou, et al.
Published: (2011-04-01)

WCN25-4505 A DESCRIPTIVE STUDY ON THE CLINICOPATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF IgA NEPHROPATHY USING THE INTERNATIONAL IgA NEPHROPATHY PREDICTION TOOL
by: Arghya Chakraborty, et al.
Published: (2025-02-01)

Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: a propensity score matched analysis
by: Dahao Zhang, et al.
Published: (2025-12-01)

WCN25-932 STEROID (SYSTEMIC OR ENTERIC RELEASED BUDESONIDE) REFRACTORY NEPHROTIC RANGE PROTEINURIA IN IgA NEPHROPATHY; CAN TACROLIMUS BE AN ALTERNATIVE?- A CASE SERIES
by: RAJA SINGHAL, et al.
Published: (2025-02-01)

WCN24-2410 “ASSOCIATION OF GLOMERULAR SYNDROMES WITH HISTOLOGICAL FINDINGS ACCORDING TO THE MEST-C SCORE OF THE OXFORD CLASSIFICATION IN PATIENTS WITH IgA NEPHROPATHY”
by: NIDIAANAHIMOLINA GONZÁLEZ, et al.
Published: (2024-04-01)

WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
by: Vlado Perkovic, et al.
Published: (2024-04-01)

Research status and perspective on recurrent IgA nephropathy after kidney transplantation
by: Zhang Shu-yu, et al.
Published: (2025-06-01)

Kidney Transplant Outcomes in Recurrent Versus De Novo IgA Nephropathy
by: Mark Haas, et al.
Published: (2025-08-01)

WCN25-1709 Salivary and Urinary Metabolomics Study in IgA Nephropathy Patients
by: Rümeyza Kazancıoğlu, et al.
Published: (2025-02-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
by: Uptal Patel, et al.
Published: (2025-02-01)

WCN25-1449 FAMILIAL IGA NEPHROPATHY: A PERPLEXING CONUNDRUM IN A FAMILY
by: MANJARI BHAT, et al.
Published: (2025-02-01)

WCN24-861 SUBCLINICAL RHABDOMYOLYSIS IN MESOAMERICAN NEPHROPATHY
by: Magdalena Madero, et al.
Published: (2024-04-01)

Short-term outcome after simultaneous pancreas-kidney transplantation with alemtuzumab vs. basiliximab induction: a single-center retrospective study
by: Tim D. A. Swaab, et al.
Published: (2025-07-01)

WCN24-342 ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19
by: Jonathan Barratt, et al.
Published: (2024-04-01)

WCN24-912 IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY
by: Jonathan Barratt, et al.
Published: (2024-04-01)

IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01)

WCN25-4245 A CASE SERIES OF CONCURRENT IGA NEPHROPATHY AND ANTI- GBM DISEASE
by: Priyangani Lohia, et al.
Published: (2025-02-01)